Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?
Open Access
- 8 April 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 28 (8) , e600-e605
Abstract
Background: Positron emission tomography/computed tomography (PET/CT) has become in recent years a tool for breast cancer (BC) staging. However, its accuracy to detect bone metastases is classically considered inferior to bone scintigraphy (BS). The purpose of this work is to compare the effectiveness of bone metastases detection between PET/CT and BS. Materials and Methods: Prospective study of 410 female patients treated in a Comprehensive Cancer Center between 2014 and 2020 that performed PET/CT and BS for staging purposes. The image analysis was performed by 2 senior nuclear medicine physicians. The comparison was performed based on accuracy, sensitivity, and specificity on a patient and anatomical region level and was assessed using McNemar’s Test. An average ROC was calculated for the anatomical region analysis. Results: PET/CT presented higher values of accuracy and sensitivity (98.0% and 93.83%), surpassing BS (95.61% and 81.48%) in detecting bone disease. There was a significant difference in favor of PET/CT (sensitivity 93.83% vs. 81.48%), however, there is no significant difference in eliminating false positives (specificity 99.09% vs. 99.09%). PET/CT presented the highest accuracy and sensitivity values for most of the bone segments, only surpassed by BS for the cranium. There was a significant difference in favor of PET/CT in the upper limb, spine, thorax (sternum) and lower limb (pelvis and sacrum), and in favor of BS in the cranium. The ROC showed that PET/CT has a higher sensitivity and consistency across the bone segments. Conclusion: With the correct imaging protocol, PET/CT does not require BS for patients with BC staging.Keywords
Funding Information
- Foundation for Science and Technology
- national funds
- Portuguese Institute of Oncology of Porto Francisco Gentil
- Portuguese Funding Institution Foundation for Science and Technology (2020.05488.BD)
This publication has 29 references indexed in Scilit:
- Does McNemar’s test compare the sensitivities and specificities of two diagnostic tests?Statistical Methods in Medical Research, 2016
- Significance of Hormone Receptor Status in Comparison of 18F -FDG-PET/CT and 99mTc-MDP Bone Scintigraphy for Evaluating Bone Metastases in Patients with Breast Cancer: Single Center ExperienceAsian Pacific Journal of Cancer Prevention, 2015
- Bone health in cancer patients: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2014
- Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancerActa Radiologica, 2011
- Factors associated with mortality after breast cancer metastasisCancer Causes & Control, 2011
- “One-stop-shop” staging: Should we prefer FDG-PET/CT or MRI for the detection of bone metastases?European Journal of Radiology, 2011
- A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancerSkeletal Radiology, 2010
- Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indicationsAnnals of Oncology, 2005
- Gene expression profiles of primary breast tumors maintained in distant metastasesProceedings of the National Academy of Sciences, 2003
- Note on the Sampling Error of the Difference Between Correlated Proportions or PercentagesPsychometrika, 1947